Petros Pharmaceuticals, Inc. (PTPI) Net income 2020–2025
Petros Pharmaceuticals, Inc. (PTPI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.9MFY2025 · since FY2020: -$20.6M → $1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9M | +113.4% |
| FY2024 | -$14.3M | -75.4% |
| FY2023 | -$8.2M | +59.3% |
| FY2022 | -$20.0M | -123.0% |
| FY2021 | -$9.0M | +56.3% |
| FY2020 | -$20.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net marginPTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →